참고 답변
My approach to portfolio diversification and managing concentration risk is rooted in a disciplined framework that aims to optimize risk-adjusted returns while adhering strictly to our firm's risk appetite. Diversification is paramount, and I implement it across multiple dimensions to reduce idiosyncratic and systemic risks. First, I ensure diversification by obligor. I maintain strict limits on single-name exposure. For example, I typically cap our exposure to any single corporate entity at 2% of the total portfolio's market value, or less for lower-rated credits. If a new opportunity arises that would breach this limit, I either pass on the deal or only take a smaller allocation, regardless of how attractive the individual credit may seem. This prevents the underperformance or default of one or two large positions from disproportionately impacting the entire portfolio.
Second, I diversify by industry sector. I set clear target ranges and hard limits for exposure to specific Global Industry Classification Standard (GICS) sectors. For instance, our internal guidelines might dictate that no single sector can exceed 10-12% of the portfolio, and we monitor this religiously. During the energy price downturn in 2020, our portfolio's energy exposure initially rose to 13% due to valuation changes and existing positions. I actively reduced this over the subsequent months, selling off some higher-beta names and reallocating capital to sectors like healthcare and technology, which showed lower correlation to commodity cycles at the time. This ensured we weren't overly reliant on the fortunes of one industry. I also consider sub-sector diversification to avoid "hidden" concentrations within broader categories. For example, within manufacturing, I'd differentiate between automotive suppliers, aerospace components, and industrial machinery, recognizing their distinct cyclicality.
Geographic diversification is another key pillar. While our primary focus might be North American credits, I'll intentionally seek out opportunities in other developed markets or select emerging markets to reduce dependence on a single economic region. I've allocated a portion of our portfolio to European investment-grade corporate bonds, for example, to gain exposure to different economic cycles and regulatory environments. This helps mitigate the impact of localized economic downturns or policy shifts.
Beyond these traditional dimensions, I also diversify by credit rating and tenor. I maintain a target mix of investment-grade and high-yield credits, ensuring we don't drift too far into either end of the spectrum without explicit strategic intent. I also manage the average duration of the portfolio, spreading out maturities to avoid large re-financing risks at any one point in time. For example, I wouldn't let more than 15% of our portfolio mature in any given 12-month period.
To actively manage concentration risk, I utilize quantitative tools. I regularly run concentration reports that highlight our largest exposures across all these dimensions. I also use Credit VaR and Expected Shortfall metrics, breaking them down by sector and obligor, to understand where our risk capital is most heavily allocated. If these tools flag a potential concentration, I immediately investigate the underlying drivers and formulate a plan to rebalance the portfolio, either through new investments in underrepresented areas, gradual sales of overweight positions, or the judicious use of credit default swaps to hedge specific concentrated exposures. For example, a few years ago, our models highlighted an increasing concentration in regional banks due to several attractive new issuances. I then paused new investments in that sub-sector for two quarters and prioritized opportunities in industrial and consumer staples to bring the concentration back within our target range. It's a continuous process of monitoring, assessing, and adjusting.